Ethylmethylthiambutene
This is an old revision of this page, as edited by Headbomb (talk | contribs) at 13:54, 18 August 2017 (clean up, journal names, mostly, replaced: British journal of pharmacology → British Journal of Pharmacology, British Journal of Pharmacology and chemotherapy → British Journal of Pharmacology and Chemotherapy using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.482 ![]() |
Chemical and physical data | |
Formula | C15H19NS2 |
Molar mass | 277.45 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Ethylmethylthiambutene (N-ethyl-N-methyl-1-methyl-3,3-di-2-thienylallylamine; Emethibutin) is an opioid analgesic drug from the thiambutene family, around 1.3x the potency of morphine.[1][2][3] It is under international control under Schedule I of the UN Single Convention On Narcotic Drugs 1961, presumably due to high abuse potential. It is a Schedule I controlled substance in the United States with a DEA ACSCN of 9623 and zero annual manufacturing quota as of 2013.[citation needed]
References
- ^ Adamson, DW; Green, AF (1950). "A new series of analgesics". Nature. 165 (4186): 122–122. doi:10.1038/165122a0. PMID 15409854.
- ^ Adamson, DW; Duffin, WM; Green, AF (1951). "Dithienylbutylamines as analgesics". Nature. 167 (4239): 153–4. doi:10.1038/167153b0. PMID 14806409.
- ^ Green, AF (1953). "Analgesic and other properties of 3: 3-dithienylalkenylamines". British Journal of Pharmacology and Chemotherapy. 8 (1): 2–9. doi:10.1111/j.1476-5381.1953.tb00739.x. PMC 1509239. PMID 13066683.
μ-opioid (MOR) |
| ||||
---|---|---|---|---|---|
δ-opioid (DOR) |
| ||||
κ-opioid (KOR) |
| ||||
Nociceptin (NOP) |
| ||||
Others |
|